The Interaction between Respiratory Pathogens and Mucus

Cell Host and Microbe

Volumn 19, Issue 2, 2016, Pages 159-168

  Zanin, Mark ^a   Baviskar, Pradyumna ^a   Webster, Robert ^a   Webby, Richard ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; MUCIN 1; MUCIN 5AC; MUCIN 5B; SIALIC ACID DERIVATIVE; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

BACTERIAL COLONIZATION; CYSTIC FIBROSIS; HOST PATHOGEN INTERACTION; HOST RANGE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA VIRUS; MUCUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; VIRAL PHENOMENA AND FUNCTIONS; VIROLOGY;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; MUCUS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 85011961550     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2016.01.001     Document Type: Review

References (110)

1. Aherne, W., Bird, T., Court, S.D., Gardner, P.S., McQuillin, J., Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23 (1970), 7–18.
2. Ambort, D., Johansson, M.E., Gustafsson, J.K., Ermund, A., Hansson, G.C., Perspectives on mucus properties and formation—lessons from the biochemical world. Cold Spring Harb. Perspect. Med., 2, 2012, a014159.
3. Ambort, D., Johansson, M.E., Gustafsson, J.K., Nilsson, H.E., Ermund, A., Johansson, B.R., Koeck, P.J., Hebert, H., Hansson, G.C., Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin. Proc. Natl. Acad. Sci. USA 109 (2012), 5645–5650.
4. Anderson, S.G., Burnet, F.M., et al. Mucins and mucoids in relation to influenza virus action; general discussion. Aust. J. Exp. Biol. Med. Sci. 26 (1948), 403–411.
5. Andrewes, C.H., NOMENCLATURE of viruses. Nature 173 (1954), 620–621.
6. Baños-Lara Mdel, R., Piao, B., Guerrero-Plata, A., Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells. Mediators Inflamm., 2015, 2015, 347292.
7. Bataki, E.L., Evans, G.S., Everard, M.L., Respiratory syncytial virus and neutrophil activation. Clin. Exp. Immunol. 140 (2005), 470–477.
8. Berger, M., Lung inflammation early in cystic fibrosis: bugs are indicted, but the defense is guilty. Am. J. Respir. Crit. Care Med. 165 (2002), 857–858.
9. Blumenkrantz, D., Roberts, K.L., Shelton, H., Lycett, S., Barclay, W.S., The short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferrets. J. Virol. 87 (2013), 10539–10551.
10. Boyoglu-Barnum, S., Gaston, K.A., Todd, S.O., Boyoglu, C., Chirkova, T., Barnum, T.R., Jorquera, P., Haynes, L.M., Tripp, R.A., Moore, M.L., Anderson, L.J., A respiratory syncytial virus (RSV) anti-G protein F(ab’)2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice. J. Virol. 87 (2013), 10955–10967.
11. Brockhausen, I., Schachter, H., Glycosyltransferases involved in N- and O-glycan biosynthesis. Gabius, H., Gabius, S., (eds.) Glycosciences: Status and Perspective, 1997, Wiley-VCH, Weinheim, Germany, 79–100.
12. Brockhausen, I., Schachter, H., Stanley, P., O-GalNAc glycans. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., (eds.) Essentials of Glycobiology, Second Edition, 2009, Cold Spring Harbor Laboratory Press, New York.
13. Burnet, F.M., Enzymic action of influenza viruses on glandular mucin and on purified blood group substances. Aust. J. Sci., 10, 1947, 21.
14. Burnet, F.M., Mucoproteins in relation to virus action. Physiol. Rev. 31 (1951), 131–150.
15. Button, B., Cai, L.H., Ehre, C., Kesimer, M., Hill, D.B., Sheehan, J.K., Boucher, R.C., Rubinstein, M., A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 337 (2012), 937–941.
16. Castrucci, M.R., Kawaoka, Y., Biologic importance of neuraminidase stalk length in influenza A virus. J. Virol. 67 (1993), 759–764.
17. Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T.M., Sasisekharan, V., Sasisekharan, R., Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26 (2008), 107–113.
18. Chen, Y., Thai, P., Zhao, Y.H., Ho, Y.S., DeSouza, M.M., Wu, R., Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278 (2003), 17036–17043.
19. Childs, R.A., Palma, A.S., Wharton, S., Matrosovich, T., Liu, Y., Chai, W., Campanero-Rhodes, M.A., Zhang, Y., Eickmann, M., Kiso, M., et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol. 27 (2009), 797–799.
20. Chou, H.H., Takematsu, H., Diaz, S., Iber, J., Nickerson, E., Wright, K.L., Muchmore, E.A., Nelson, D.L., Warren, S.T., Varki, A., A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 95 (1998), 11751–11756.
21. Chu, V.C., Whittaker, G.R., Influenza virus entry and infection require host cell N-linked glycoprotein. Proc. Natl. Acad. Sci. USA 101 (2004), 18153–18158.
22. Cohen, M., Zhang, X.Q., Senaati, H.P., Chen, H.W., Varki, N.M., Schooley, R.T., Gagneux, P., Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol. J., 10, 2013, 321.
23. Collins, P.L., Crowe, J.E. Jr., Respiratory syncytial virus and metapneumovirus. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 2013, Lippincott Williams & Wilkins, Philadelphia, 1601–1646.
24. Colomb, F., Vidal, O., Bobowski, M., Krzewinski-Recchi, M.A., Harduin-Lepers, A., Mensier, E., Jaillard, S., Lafitte, J.J., Delannoy, P., Groux-Degroote, S., TNF induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases and increases FliD/sialyl-Lewis(x)-mediated adhesion of Pseudomonas aeruginosa. Biochem. J. 457 (2014), 79–87.
25. Connors, M., Collins, P.L., Firestone, C.Y., Murphy, B.R., Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65 (1991), 1634–1637.
26. Corfield, A.P., Wagner, S.A., Clamp, J.R., Kriaris, M.S., Hoskins, L.C., Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 60 (1992), 3971–3978.
27. Davril, M., Degroote, S., Humbert, P., Galabert, C., Dumur, V., Lafitte, J.J., Lamblin, G., Roussel, P., The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology 9 (1999), 311–321.
28. de Vries, E., de Vries, R.P., Wienholts, M.J., Floris, C.E., Jacobs, M.S., van den Heuvel, A., Rottier, P.J., de Haan, C.A., Influenza A virus entry into cells lacking sialylated N-glycans. Proc. Natl. Acad. Sci. USA 109 (2012), 7457–7462.
29. Ehre, C., Worthington, E.N., Liesman, R.M., Grubb, B.R., Barbier, D., O'Neal, W.K., Sallenave, J.M., Pickles, R.J., Boucher, R.C., Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl. Acad. Sci. USA 109 (2012), 16528–16533.
30. Gagneux, P., Cheriyan, M., Hurtado-Ziola, N., van der Linden, E.C., Anderson, D., McClure, H., Varki, A., Varki, N.M., Human-specific regulation of alpha 2-6-linked sialic acids. J. Biol. Chem. 278 (2003), 48245–48250.
31. Gambaryan, A., Webster, R., Matrosovich, M., Differences between influenza virus receptors on target cells of duck and chicken. Arch. Virol. 147 (2002), 1197–1208.
32. Ganesan, S., Comstock, A.T., Sajjan, U.S., Barrier function of airway tract epithelium. Tissue Barriers, 1, 2013, e24997.
33. Gibson, R.L., Burns, J.L., Ramsey, B.W., Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168 (2003), 918–951.
34. Gottschalk, A., Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. Biochim. Biophys. Acta 23 (1957), 645–646.
35. Groux-Degroote, S., Krzewinski-Recchi, M.A., Cazet, A., Vincent, A., Lehoux, S., Lafitte, J.J., Van Seuningen, I., Delannoy, P., IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem. J. 410 (2008), 213–223.
36. Hartl, D., Gaggar, A., Bruscia, E., Hector, A., Marcos, V., Jung, A., Greene, C., McElvaney, G., Mall, M., Döring, G., Innate immunity in cystic fibrosis lung disease. J. Cyst. Fibros. 11 (2012), 363–382.
37. Hashimoto, K., Graham, B.S., Ho, S.B., Adler, K.B., Collins, R.D., Olson, S.J., Zhou, W., Suzutani, T., Jones, P.W., Goleniewska, K., et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am. J. Respir. Crit. Care Med. 170 (2004), 306–312.
38. Hashimoto, K., Durbin, J.E., Zhou, W., Collins, R.D., Ho, S.B., Kolls, J.K., Dubin, P.J., Sheller, J.R., Goleniewska, K., O'Neal, J.F., et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116 (2005), 550–557.
39. Hoskins, L.C., Boulding, E.T., Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes. J. Clin. Invest. 67 (1981), 163–172.
40. Hotard, A.L., Lee, S., Currier, M.G., Crowe, J.E. Jr., Sakamoto, K., Newcomb, D.C., Peebles, R.S. Jr., Plemper, R.K., Moore, M.L., Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J. Virol. 89 (2015), 512–522.
41. Hovenberg, H.W., Davies, J.R., Carlstedt, I., Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 318 (1996), 319–324.
42. Hoyert, D.L., Xu, J., Deaths: preliminary data for 2011. Natl. Vital Stat. Rep. 61 (2012), 1–51.
43. Irie, A., Koyama, S., Kozutsumi, Y., Kawasaki, T., Suzuki, A., The molecular basis for the absence of N-glycolylneuraminic acid in humans. J. Biol. Chem. 273 (1998), 15866–15871.
44. Ito, T., Couceiro, J.N., Kelm, S., Baum, L.G., Krauss, S., Castrucci, M.R., Donatelli, I., Kida, H., Paulson, J.C., Webster, R.G., Kawaoka, Y., Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72 (1998), 7367–7373.
45. x to increase binding to airway epithelial cells. Mucosal Immunol., 2015, 10.1038/mi.2015.119 Published online November 11, 2015.
46. Jia, N., Barclay, W.S., Roberts, K., Yen, H.L., Chan, R.W., Lam, A.K., Air, G., Peiris, J.S., Dell, A., Nicholls, J.M., Haslam, S.M., Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies. J. Biol. Chem. 289 (2014), 28489–28504.
47. Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., Pickles, R.J., Sheehan, J.K., Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 23 (2009), 1858–1868.
48. Kobasa, D., Kodihalli, S., Luo, M., Castrucci, M.R., Donatelli, I., Suzuki, Y., Suzuki, T., Kawaoka, Y., Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J. Virol. 73 (1999), 6743–6751.
49. Lai, S.K., Wang, Y.Y., Wirtz, D., Hanes, J., Micro- and macrorheology of mucus. Adv. Drug Deliv. Rev. 61 (2009), 86–100.
50. Lang, T., Hansson, G.C., Samuelsson, T., Gel-forming mucins appeared early in metazoan evolution. Proc. Natl. Acad. Sci. USA 104 (2007), 16209–16214.
51. Laver, W.G., Colman, P.M., Webster, R.G., Hinshaw, V.S., Air, G.M., Influenza virus neuraminidase with hemagglutinin activity. Virology 137 (1984), 314–323.
52. Li, J.D., Dohrman, A.F., Gallup, M., Miyata, S., Gum, J.R., Kim, Y.S., Nadel, J.A., Prince, A., Basbaum, C.B., Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc. Natl. Acad. Sci. USA 94 (1997), 967–972.
53. Li, Y., Dinwiddie, D.L., Harrod, K.S., Jiang, Y., Kim, K.C., Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 298 (2010), L558–L563.
54. Li, W., Yan, F., Zhou, H., Lin, X., Wu, Y., Chen, C., Zhou, N., Chen, Z., Li, J.D., Shen, H., P. aeruginosa lipopolysaccharide-induced MUC5AC and CLCA3 expression is partly through Duox1 in vitro and in vivo. PLoS ONE, 8, 2013, e63945.
55. Lillehoj, E.P., Kim, B.T., Kim, K.C., Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002), L751–L756.
56. Lillehoj, E.P., Hyun, S.W., Feng, C., Zhang, L., Liu, A., Guang, W., Nguyen, C., Luzina, I.G., Atamas, S.P., Passaniti, A., et al. NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. J. Biol. Chem. 287 (2012), 8214–8231.
57. Lillehoj, E.P., Kato, K., Lu, W., Kim, K.C., Cellular and molecular biology of airway mucins. Int. Rev. Cell Mol. Biol. 303 (2013), 139–202.
58. Lin, Y.P., Gregory, V., Collins, P., Kloess, J., Wharton, S., Cattle, N., Lackenby, A., Daniels, R., Hay, A., Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J. Virol. 84 (2010), 6769–6781.
59. Lora, J.M., Zhang, D.M., Liao, S.M., Burwell, T., King, A.M., Barker, P.A., Singh, L., Keaveney, M., Morgenstern, J., Gutiérrez-Ramos, J.C., et al. Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. J. Biol. Chem. 280 (2005), 36510–36517.
60. Lovewell, R.R., Hayes, S.M., O'Toole, G.A., Berwin, B., Pseudomonas aeruginosa flagellar motility activates the phagocyte PI3K/Akt pathway to induce phagocytic engulfment. Am. J. Physiol. Lung Cell. Mol. Physiol. 306 (2014), L698–L707.
61. Lu, W., Hisatsune, A., Koga, T., Kato, K., Kuwahara, I., Lillehoj, E.P., Chen, W., Cross, A.S., Gendler, S.J., Gewirtz, A.T., Kim, K.C., Cutting edge: enhanced pulmonary clearance of Pseudomonas aeruginosa by Muc1 knockout mice. J. Immunol. 176 (2006), 3890–3894.
62. Luan, X., Campanucci, V.A., Nair, M., Yilmaz, O., Belev, G., Machen, T.E., Chapman, D., Ianowski, J.P., Pseudomonas aeruginosa triggers CFTR-mediated airway surface liquid secretion in swine trachea. Proc. Natl. Acad. Sci. USA 111 (2014), 12930–12935.
63. Luzar, M.A., Thomassen, M.J., Montie, T.C., Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect. Immun. 50 (1985), 577–582.
64. Martino, M.B., Jones, L., Brighton, B., Ehre, C., Abdulah, L., Davis, C.W., Ron, D., O'Neal, W.K., Ribeiro, C.M., The ER stress transducer IRE1β is required for airway epithelial mucin production. Mucosal Immunol. 6 (2013), 639–654.
65. Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M.R., Donatelli, I., Kawaoka, Y., Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74 (2000), 8502–8512.
66. Matrosovich, M.N., Matrosovich, T.Y., Gray, T., Roberts, N.A., Klenk, H.D., Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 78 (2004), 12665–12667.
67. Matsuoka, Y., Swayne, D.E., Thomas, C., Rameix-Welti, M.A., Naffakh, N., Warnes, C., Altholtz, M., Donis, R., Subbarao, K., Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J. Virol. 83 (2009), 4704–4708.
68. Miller, A.L., Strieter, R.M., Gruber, A.D., Ho, S.B., Lukacs, N.W., CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J. Immunol. 170 (2003), 3348–3356.
69. Ng, P.S., Böhm, R., Hartley-Tassell, L.E., Steen, J.A., Wang, H., Lukowski, S.W., Hawthorne, P.L., Trezise, A.E., Coloe, P.J., Grimmond, S.M., et al. Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors. Nat. Commun., 5, 2014, 5750.
70. Nicholls, J.M., Bourne, A.J., Chen, H., Guan, Y., Peiris, J.S., Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir. Res., 8, 2007, 73.
71. Ohuchi, M., Asaoka, N., Sakai, T., Ohuchi, R., Roles of neuraminidase in the initial stage of influenza virus infection. Microbes Infect. 8 (2006), 1287–1293.
72. Palese, P., Shaw, M.L., Orthomyxoviridae: the viruses and their replication. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 2013, Lippincott Williams & Wilkins, Philadelphia, 1647–1689.
73. Pastoriza Gallego, M., Hulen, C., Influence of sialic acid and bacterial sialidase on differential adhesion of Pseudomonas aeruginosa to epithelial cells. Colloids Surf. B Biointerfaces 52 (2006), 154–156.
74. Persson, B.D., Jaffe, A.B., Fearns, R., Danahay, H., Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS ONE, 9, 2014, e102368.
75. Pickles, R.J., DeVincenzo, J.P., Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J. Pathol. 235 (2015), 266–276.
76. Pietrantoni, A., Ammendolia, M.G., Superti, F., Bovine lactoferrin: involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection. Biochem. Cell Biol. 90 (2012), 442–448.
77. Puchelle, E., Zahm, J.M., Havez, R., [Biochemical and rheological data in sputum. 3. Relationship between the biochemical constituents and the rheological properties of sputum (author's transl)]. Bull. Physiopathol. Respir. (Nancy) 9 (1973), 237–257.
78. Rada, B., Gardina, P., Myers, T.G., Leto, T.L., Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin. Mucosal Immunol. 4 (2011), 158–171.
79. Ridley, C., Kouvatsos, N., Raynal, B.D., Howard, M., Collins, R.F., Desseyn, J.L., Jowitt, T.A., Baldock, C., Davis, C.W., Hardingham, T.E., Thornton, D.J., Assembly of the respiratory mucin MUC5B: a new model for a gel-forming mucin. J. Biol. Chem. 289 (2014), 16409–16420.
80. Roy, M.G., Livraghi-Butrico, A., Fletcher, A.A., McElwee, M.M., Evans, S.E., Boerner, R.M., Alexander, S.N., Bellinghausen, L.K., Song, A.S., Petrova, Y.M., et al. Muc5b is required for airway defence. Nature 505 (2014), 412–416.
81. Scharfman, A., Degroote, S., Beau, J., Lamblin, G., Roussel, P., Mazurier, J., Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates. Glycobiology 9 (1999), 757–764.
82. Schauer, R., Srinivasan, G.V., Coddeville, B., Zanetta, J.P., Guérardel, Y., Low incidence of N-glycolylneuraminic acid in birds and reptiles and its absence in the platypus. Carbohydr. Res. 344 (2009), 1494–1500.
83. Sheehan, J.K., Kesimer, M., Pickles, R., Innate immunity and mucus structure and function. Novartis Found. Symp. 279 (2006), 155–166 discussion 167–159, 216–159.
84. Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., Kawaoka, Y., Avian flu: influenza virus receptors in the human airway. Nature 440 (2006), 435–436.
85. Shogren, R., Gerken, T.A., Jentoft, N., Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light-scattering studies of ovine submaxillary mucin. Biochemistry 28 (1989), 5525–5536.
86. Springer, S.A., Gagneux, P., Glycan evolution in response to collaboration, conflict, and constraint. J. Biol. Chem. 288 (2013), 6904–6911.
87. Springer, S.A., Diaz, S.L., Gagneux, P., Parallel evolution of a self-signal: humans and new world monkeys independently lost the cell surface sugar Neu5Gc. Immunogenetics 66 (2014), 671–674.
88. Stanley, P., Schachter, H., Taniguchi, N., N-glycans. Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., (eds.) Essentials of Glycobiology, Second Edition, 2009, Cold Spring Harbor Laboratory Press, New York.
89. Staudinger, B.J., Muller, J.F., Halldórsson, S., Boles, B., Angermeyer, A., Nguyen, D., Rosen, H., Baldursson, O., Gottfreðsson, M., Guðmundsson, G.H., Singh, P.K., Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 189 (2014), 812–824.
90. Stevens, J., Blixt, O., Glaser, L., Taubenberger, J.K., Palese, P., Paulson, J.C., Wilson, I.A., Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355 (2006), 1143–1155.
91. Stokes, K.L., Currier, M.G., Sakamoto, K., Lee, S., Collins, P.L., Plemper, R.K., Moore, M.L., The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J. Virol. 87 (2013), 10070–10082.
92. Stone, J.D., Tryptic inactivation of the receptor-destroying enzeme of V. cholerae and of the enzymic activity of influenza virus. Aust. J. Exp. Biol. Med. Sci. 27 (1949), 229–244.
93. Suzuki, Y., Ito, T., Suzuki, T., Holland, R.E. Jr., Chambers, T.M., Kiso, M., Ishida, H., Kawaoka, Y., Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 74 (2000), 11825–11831.
94. Takahashi, T., Takano, M., Kurebayashi, Y., Masuda, M., Kawagishi, S., Takaguchi, M., Yamanaka, T., Minami, A., Otsubo, T., Ikeda, K., Suzuki, T., N-glycolylneuraminic acid on human epithelial cells prevents entry of influenza A viruses that possess N-glycolylneuraminic acid binding ability. J. Virol. 88 (2014), 8445–8456.
95. Temann, U.A., Prasad, B., Gallup, M.W., Basbaum, C., Ho, S.B., Flavell, R.A., Rankin, J.A., A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16 (1997), 471–478.
96. Thornton, D.J., Rousseau, K., McGuckin, M.A., Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 70 (2008), 459–486.
97. Tumpey, T.M., Maines, T.R., Van Hoeven, N., Glaser, L., Solórzano, A., Pappas, C., Cox, N.J., Swayne, D.E., Palese, P., Katz, J.M., García-Sastre, A., A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315 (2007), 655–659.
98. Umehara, T., Kato, K., Park, Y.S., Lillehoj, E.P., Kawauchi, H., Kim, K.C., Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection. Inflamm. Res. 61 (2012), 1013–1020.
99. van Riel, D., Munster, V.J., de Wit, E., Rimmelzwaan, G.F., Fouchier, R.A., Osterhaus, A.D., Kuiken, T., H5N1 virus attachment to lower respiratory tract. Science, 312, 2006, 399.
100. Verdugo, P., Aitken, M., Langley, L., Villalon, M.J., Molecular mechanism of product storage and release in mucin secretion. II. The role of extracellular Ca++. Biorheology 24 (1987), 625–633.
101. Verdugo, P., Deyrup-Olsen, I., Aitken, M., Villalon, M., Johnson, D., Molecular mechanism of mucin secretion: I. The role of intragranular charge shielding. J. Dent. Res. 66 (1987), 506–508.
102. Wakabayashi, H., Oda, H., Yamauchi, K., Abe, F., Lactoferrin for prevention of common viral infections. J. Infect. Chemother. 20 (2014), 666–671.
103. Wickström, C., Davies, J.R., Eriksen, G.V., Veerman, E.C., Carlstedt, I., MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334 (1998), 685–693.
104. Yan, F., Li, W., Jono, H., Li, Q., Zhang, S., Li, J.D., Shen, H., Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells. Biochem. Biophys. Res. Commun. 366 (2008), 513–519.
105. Yang, X., Steukers, L., Forier, K., Xiong, R., Braeckmans, K., Van Reeth, K., Nauwynck, H., A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus. PLoS ONE, 9, 2014, e110026.
106. Yeung, A.T., Parayno, A., Hancock, R.E., Mucin promotes rapid surface motility in Pseudomonas aeruginosa. MBio, 3, 2012 e00073-12.
107. Zanin, M., Marathe, B., Wong, S.S., Yoon, S.W., Collin, E., Oshansky, C., Jones, J., Hause, B., Webby, R., Pandemic swine H1N1 influenza viruses with almost undetectable neuraminidase activity do not transmit via aerosols in ferrets and are inhibited by human mucus, but not swine mucus. J. Virol. 89 (2015), 5935–5948.
108. Zheng, S., Xu, W., Bose, S., Banerjee, A.K., Haque, S.J., Erzurum, S.C., Impaired nitric oxide synthase-2 signaling pathway in cystic fibrosis airway epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 287 (2004), L374–L381.
109. Zhu, X., McBride, R., Nycholat, C.M., Yu, W., Paulson, J.C., Wilson, I.A., Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors. J. Virol. 86 (2012), 13371–13383.
110. Zuhdi Alimam, M., Piazza, F.M., Selby, D.M., Letwin, N., Huang, L., Rose, M.C., Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am. J. Respir. Cell Mol. Biol. 22 (2000), 253–260.